News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
727,642 Results
Type
Article (43945)
Company Profile (720)
Press Release (682968)
Multimedia
Podcasts (153)
Webinars (25)
Section
Business (210763)
Career Advice (2658)
Deals (37083)
Drug Delivery (134)
Drug Development (81996)
Employer Resources (178)
FDA (16350)
Job Trends (15702)
News (354314)
Policy (32139)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2032)
Academic (2)
Accelerated approval (33)
Adcomms (24)
Allergies (150)
Alliances (51751)
ALS (181)
Alzheimer's disease (1701)
Antibody-drug conjugate (ADC) (336)
Approvals (16591)
Artificial intelligence (575)
Autoimmune disease (177)
Automation (37)
Bankruptcy (383)
Best Places to Work (11637)
BIOSECURE Act (23)
Biosimilars (193)
Biotechnology (448)
Bladder cancer (153)
Brain cancer (58)
Breast cancer (641)
Cancer (4892)
Cardiovascular disease (429)
Career advice (2252)
Career pathing (41)
CAR-T (292)
CDC (38)
Celiac Disease (1)
Cell therapy (804)
Cervical cancer (37)
Clinical research (70138)
Collaboration (1831)
Company closure (5)
Compensation (1184)
Complete response letters (73)
COVID-19 (2654)
CRISPR (98)
C-suite (921)
Cystic fibrosis (149)
Data (6311)
Decentralized trials (2)
Denatured (47)
Depression (147)
Diabetes (507)
Diagnostics (6906)
Digital health (50)
Diversity (8)
Diversity, equity & inclusion (42)
Drug discovery (273)
Drug pricing (202)
Drug shortages (33)
Duchenne muscular dystrophy (239)
Earnings (91420)
Editorial (63)
Employer branding (24)
Employer resources (158)
Events (121911)
Executive appointments (1035)
FDA (19505)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (10)
Frontotemporal dementia (22)
Funding (1533)
Gene editing (214)
Generative AI (58)
Gene therapy (650)
GLP-1 (1058)
Government (3968)
Grass and pollen (8)
Guidances (381)
Healthcare (18057)
HIV (62)
Huntington's disease (49)
IgA nephropathy (87)
Immunology and inflammation (284)
Immuno-oncology (64)
Indications (115)
Infectious disease (2933)
Inflammatory bowel disease (204)
Inflation Reduction Act (15)
Influenza (122)
Intellectual property (261)
Interviews (514)
IPO (17445)
IRA (55)
Job creations (4451)
Job search strategy (1840)
JPM (65)
Kidney cancer (15)
Labor market (85)
Layoffs (642)
Leadership (38)
Legal (8148)
Liver cancer (92)
Longevity (15)
Lung cancer (653)
Lymphoma (371)
Machine learning (42)
Management (62)
Manufacturing (854)
MASH (174)
Medical device (14324)
Medtech (14383)
Mergers & acquisitions (20730)
Metabolic disorders (1341)
Multiple sclerosis (164)
NASH (19)
Neurodegenerative disease (349)
Neuropsychiatric disorders (99)
Neuroscience (3010)
Neurotech (1)
NextGen: Class of 2026 (6658)
Non-profit (3536)
Now hiring (69)
Obesity (646)
Opinion (324)
Ovarian cancer (163)
Pain (208)
Pancreatic cancer (237)
Parkinson's disease (293)
Partnered (36)
Patents (525)
Patient recruitment (512)
Peanut (60)
People (61222)
Pharmaceutical (134)
Pharmacy benefit managers (28)
Phase 1 (21873)
Phase 2 (30989)
Phase 3 (23251)
Pipeline (5473)
Policy (297)
Postmarket research (2406)
Preclinical (9142)
Press Release (66)
Prostate cancer (244)
Psychedelics (55)
Radiopharmaceuticals (302)
Rare diseases (904)
Real estate (6191)
Recruiting (77)
Regulatory (24515)
Reports (46)
Research institute (1998)
Resumes & cover letters (408)
Rett syndrome (27)
RNA editing (19)
RSV (82)
Schizophrenia (157)
Series A (262)
Series B (203)
Service/supplier (27)
Sickle cell disease (102)
Special edition (26)
Spinal muscular atrophy (161)
Sponsored (39)
Startups (3995)
State (2)
Stomach cancer (20)
Supply chain (109)
Tariffs (96)
The Weekly (104)
Vaccines (1050)
Venture capital (100)
Weight loss (430)
Women's health (85)
Worklife (22)
Date
Today (103)
Last 7 days (559)
Last 30 days (2400)
Last 365 days (31183)
2026 (4043)
2025 (31491)
2024 (36507)
2023 (41242)
2022 (51828)
2021 (55706)
2020 (53613)
2019 (45966)
2018 (34977)
2017 (33953)
2016 (32973)
2015 (38586)
2014 (32085)
2013 (27502)
2012 (28747)
2011 (28735)
2010 (26829)
Location
Africa (856)
Alabama (92)
Alaska (6)
Arizona (264)
Arkansas (12)
Asia (43981)
Australia (7269)
California (11657)
Canada (3328)
China (1172)
Colorado (488)
Connecticut (507)
Delaware (348)
Europe (97976)
Florida (1700)
Georgia (364)
Hawaii (4)
Idaho (62)
Illinois (866)
India (75)
Indiana (548)
Iowa (24)
Japan (439)
Kansas (124)
Kentucky (40)
Louisiana (27)
Maine (79)
Maryland (1342)
Massachusetts (8547)
Michigan (353)
Minnesota (654)
Mississippi (5)
Missouri (135)
Montana (35)
Nebraska (26)
Nevada (123)
New Hampshire (83)
New Jersey (3129)
New Mexico (32)
New York (3034)
North Carolina (1590)
North Dakota (9)
Northern California (5668)
Ohio (343)
Oklahoma (22)
Oregon (51)
Pennsylvania (2328)
Puerto Rico (25)
Rhode Island (51)
South America (1243)
South Carolina (66)
South Dakota (1)
Southern California (4471)
Tennessee (173)
Texas (1772)
United States (41380)
Utah (334)
Vermont (1)
Virginia (285)
Washington D.C. (83)
Washington State (968)
West Virginia (4)
Wisconsin (127)
Wyoming (2)
727,642 Results for "becton dickinson and company".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Becton, Dickinson and Company Announces Tender Offers for Outstanding Debt Securities
February 11, 2026
·
10 min read
Press Releases
Celltrion Pharm Signs Strategic Trilateral Agreement with Becton Dickinson and BD Korea to Accelerate Global PFS CMO Business
September 17, 2025
·
2 min read
Business
Navigate BioPharma Services, Inc. Announces Collaboration with BD (Becton, Dickinson and Company) to Advance Capabilities for Clinical Phases of Drug Development
Navigate BioPharma Services, Inc. announces a strategic collaboration with BD (Becton, Dickinson and Company) to explore opportunities to develop and commercialize flow cytometry-based companion diagnostics and tools for clinical decisions.
September 7, 2023
·
3 min read
STERIS Expands Healthcare Products Offering with Acquisition of Surgical Instrumentation Assets from Becton, Dickinson and Company for $540 million
STERIS plc announced that the Company has signed a definitive agreement to purchase the surgical instrumentation, laparoscopic instrumentation and sterilization container assets from Becton, Dickinson and Company for $540 million.
June 20, 2023
·
8 min read
Business
BD Announces Dates for Third Quarter and Fourth Quarter Fiscal 2024 Earnings Webcasts
BD (Becton, Dickinson and Company) announced today that it plans to host webcasts to discuss quarterly financial results on the following dates.
June 20, 2024
·
1 min read
Business
Becton, Dickinson and Company Announces Early Tender Results
Becton, Dickinson and Company announced the early tender results for its previously announced tender offers to purchase for cash any and all of the Company’s 2.894% senior notes due 2022 and 3.300% senior notes due 2023.
August 19, 2021
·
9 min read
Business
Galapagos appoints Andrew Dickinson as Non-Executive Non-Independent Director to its Board
Galapagos NV announced that during its meeting of 26 March 2024, the Board of Directors appointed Mr. Dickinson as Non-Executive Non-Independent Director by way of cooptation.
March 26, 2024
·
4 min read
Pharm Country
New BD Research Tool Helps Scientists Study Cells that are Often Key Culprits in the Development of Cancer and Infectious Diseases
BD (Becton, Dickinson and Company) announced the commercial launch of a new single-cell research tool to help scientists better understand how the molecular machinery within a cell functions and how it regulates changes in a cell that can lead to cancer and other diseases.
June 26, 2024
·
3 min read
Business
Armonica Technologies announces Todd Dickinson joins Board of Directors
Armonica Technologies, Inc., a pioneer in sample-prep free direct optical DNA sequencing, announced the appointment of life science leader Todd Dickinson to the Board of Directors.
March 12, 2024
·
2 min read
Pharm Country
BD to Present at Bank of America Securities Health Care Conference 2024
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Bank of America Securities Health Care Conference 2024 on Tuesday, May 14, 2024 at 11:00 am Eastern Time.
April 29, 2024
·
1 min read
1 of 72,765
Next
